The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are obesity‐related conditions with high cardiovascular mortality. Whether NAFLD is independently associated with subclinical myocardial remodeling or dysfunction among the general population is unknown. We performed a cross‐sectional analysis of 2,713 participants from the multicenter, community‐based Coronary Artery Risk Development in Young Adults (CARDIA) study who underwent concurrent computed tomography (CT) quantification of liver fat and comprehensive echocardiography with myocardial strain measured by speckle tracking during the Year‐25 examination (age, 43‐55 years; 58.8% female and 48.0% black). NAFLD was defined as liver attenuation ≤40 Hounsfield units after excluding other causes of liver fat. Subclinical left ventricular (LV) systolic dysfunction was defined using values of absolute peak global longitudinal strain (GLS). Diastolic dysfunction was defined using Doppler and tissue Doppler imaging markers. Prevalence of NAFLD was 10.0%. Participants with NAFLD had lower early diastolic relaxation (e’) velocity (10.8 ± 2.6 vs. 11.9 ± 2.8 cm/s), higher LV filling pressure (E/e’ ratio: 7.7 ± 2.6 vs. 7.0 ± 2.3), and worse absolute GLS (14.2 ± 2.4% vs. 15.2 ± 2.4%) than non‐NAFLD (P < 0.0001 for all). When adjusted for HF risk factors or body mass index, NAFLD remained associated with subclinical myocardial remodeling and dysfunction (P < 0.01). The association of NAFLD with e’ velocity (β = −0.36 [standard error = 0.15] cm/s;P = 0.02), E/e’ ratio (β = 0.35 [0.16];P = 0.03), and GLS (β = −0.42 [0.18]%;P = 0.02) was attenuated after controlling for visceral adipose tissue. Effect modification by race and sex was not observed.Conclusions:NAFLD is independently associated with subclinical myocardial remodeling and dysfunction and provides further insight into a possible link between NAFLD and HF. (H epatology 2015;62:773–783)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351 · cited 2×
“Increased LV filling pressure was defined as early transmitral velocity (E)/e’ ratio 12 alone or the combination of E/e’ ratio 8-12 and left atrial (LA) volume index 34 mL/m(2).(23) LV mass was indexed to height(2,7) and LA volume indexed to height.”
BackgroundMethodGuidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi204 · Cited by 2,260
Cardia: study design, recruitment, and some characteristics of the examined subjects
Friedman, G. D., Cutter, G. R., Donahue, R. P., Hughes, G. H., Hulley, S. B., Jacobs, D. R., Liu, K., & Savage, P. J. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90080-7 · Cited by 1,687
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Tsang, T. S. M., Barnes, M. E., Gersh, B. J., Bailey, K. R., & Seward, J. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02864-3 · Cited by 1,166
Stanton, T., Leano, R., & Marwick, T. H. (2009) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.109.862334 · Cited by 924
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Comparison of CT Methods for Determining the Fat Content of the Liver
Kodama, Y., Ng, C. S., Wu, T. T., Ayers, G. D., Curley, S. A., Abdalla, E. K., Vauthey, J. N., & Charnsangavej, C. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0992 · Cited by 514
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Ersbøll, M., Valeur, N., Mogensen, U. M., Andersen, M. J., Møller, J. E., Velazquez, E. J., Hassager, C., Søgaard, P., & Køber, L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.061 · Cited by 408
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Kankaanpää, M., Lehto, H.-R., Pärkkä, J. P., Komu, M., Viljanen, A., Ferrannini, E., Knuuti, J., Nuutila, P., Parkkola, R., & Iozzo, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0584 · Cited by 342
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310
Long-term prognostic significance of left atrial volume in acute myocardial infarction
Beinart, R., Boyko, V., Schwammenthal, E., Kuperstein, R., Sagie, A., Hod, H., Matetzky, S., Behar, S., Eldar, M., & Feinberg, M. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.062 · Cited by 288
Ballestri, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1724 · Cited by 262
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 248
Perseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
Assy, N., Djibre, A., Farah, R., Grosovski, M., & Marmor, A. (2010) · Radiology · doi:10.1148/radiol.09090769 · Cited by 192
Bonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E., & Targher, G. (2012) · Diabetes Care · doi:10.2337/dc11-1820 · Cited by 183
Lautamäki, R., Borra, R., Iozzo, P., Komu, M., Lehtimäki, T., Salmi, M., Jalkanen, S., Airaksinen, K. E. J., Knuuti, J., Parkkola, R., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00604.2005 · Cited by 170
Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A., & Malnick, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225668.53673.e6 · Cited by 162
Visceral adipose tissue area is an independent risk factor for hepatic steatosis
Park, B. J., Kim, Y. J., Kim, D., Kim, W. K., Jung, Y. J., Yoon, J., Kim, C. Y., Cho, Y. M., Kim, S. H., Lee, K. B., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05212.x · Cited by 161
Chinali, M., Devereux, R. B., Howard, B. V., Roman, M. J., Bella, J. N., Liu, J. E., Resnick, H. E., Lee, E. T., Best, L. G., & de Simone, G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.009 · Cited by 157
VanWagner, L. B., Ning, H., Lewis, C. E., Shay, C. M., Wilkins, J. T., Carr, J. J., Terry, J. G., Lloyd‐Jones, D. M., Jacobs, D. R., & Carnethon, M. R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.962 · Cited by 151
Self-citationMeris, A., Amigoni, M., Uno, H., Thune, J. J., Verma, A., Køber, L., Bourgoun, M., McMurray, J. J. V., Velazquez, E. J., Maggioni, A. P., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn499 · Cited by 138
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
Rijzewijk, L. J., Jonker, J. T., van der Meer, R. W., Lubberink, M., de Jong, H. W. A. M., Romijn, J. A., Bax, J. J., Roos, A., Heine, R. J., Twisk, J. W. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.049 · Cited by 127
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60008-2 · Cited by 119
Fallo, F., Pozza, A. D., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Piazza, L. D., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.007 · Cited by 118
Akabame, S., Hamaguchi, M., Tomiyasu, K.-I., Tanaka, M., Kobayashi-Takenaka, Y., Nakano, K., Oda, Y., & Yoshikawa, T. (2007) · Circulation Journal · doi:10.1253/circj.72.618 · Cited by 117
Fotbolcu, H., Yakar, T., Duman, D., Karaahmet, T., Tigen, K., Çevik, C., Kurtoğlu, Ü., & Dindar, İ. (2010) · PubMed · Cited by 117
Plasma Free Fatty Acids and Risk of Heart Failure: The Cardiovascular Health Study
Djoussé, L., Benkeser, D. C., Arnold, A. M., Kizer, J. R., Zieman, S. J., Lemaître, R. N., Tracy, R. P., Gottdiener, J. S., Mozaffarian, D., Siscovick, D. S., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000521 · Cited by 114
Epicardial fat thickness and coronary artery disease correlate independently of obesity
Iacobellis, G., Lonn, E., Lamy, A. L., Singh, N., & Sharma, A. M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.117 · Cited by 113
Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease
Pacifico, L., Martino, M. D., Merulis, A. D., Bezzi, M., Osborn, J. F., Catalano, C., & Chiesa, C. (2013) · Hepatology · doi:10.1002/hep.26610 · Cited by 109
Kishi, S., Armstrong, A. D. C., Gidding, S. S., Colangelo, L. A., Ambale‐Venkatesh, B., Jacobs, D. R., Carr, J. J., Terry, J. G., Liu, K., Goff, D. C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.03.001 · Cited by 108
Self-citationLongitudinal Determinants of Left Ventricular Mass and Geometry
Gidding, S. S., Liu, K., Colangelo, L. A., Cook, N. L., Goff, D. C., Glasser, S. P., Gardin, J. M., & Lima, J. A. C. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.000450 · Cited by 105
Self-citationPoulsen, M. K., Dahl, J. S., Henriksen, J. E., Hey, T. M., Høilund‐Carlsen, P. F., Beck‐Nielsen, H., & Møller, J. E. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1622 · Cited by 104
Serum γ-Glutamyl Transferase and Risk of Heart Failure in the Community
Dhingra, R., Gona, P. N., Wang, T. J., Fox, C. S., D’Agostino, R. B., & Vasan, R. S. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207340 · Cited by 102
Kim, N. H., Park, J., Kim, S. H., Kim, Y. H., Kim, D. H., Cho, G., Baik, I., Lim, H. E., Kim, E. J., Na, J. O., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305099 · Cited by 100
Liu, J., Musani, S. K., Bidulescu, A., Carr, J. J., Wilson, J. G., Taylor, H. A., & Fox, C. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.042 · Cited by 95
Self-citationTargher, G. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.005 · Cited by 86
Dahl, J. S., Videbæk, L. M., Poulsen, M. K., Pellikka, P. A., Veien, K. T., Andersen, L. I., Haghfelt, T. H., & Møller, J. E. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.01.032 · Cited by 72
Sert, A., Aypar, E., Pirgon, Ö., Yılmaz, H. S., Odabaş, D., & Tolu, İ. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.056 · Cited by 66
γ-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men
Wannamethee, S. G., Whincup, P. H., Shaper, A. G., LENNON, L. T., & Sattar, N. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240457 · Cited by 63
Karabay, C. Y., Kocabay, G., Kalaycı, A., Çolak, Y., Oduncu, V., Akgün, T., Kalkan, S., Güler, A., & Kırma, C. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000008 · Cited by 55
Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland
Wang, Y., Tuomilehto, J. O., Jousilahti, P., Salomaa, V. V., Li, B., Antikaínen, R., Mähönen, M., Katzmarzyk, P. T., & Hu, G. (2012) · Heart · doi:10.1136/heartjnl-2012-302972 · Cited by 48
Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle
Bugianesi, E. (2007) · Hepatology · doi:10.1002/hep.22105 · Cited by 36
Cited by
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Self-citationRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
Self-citationHypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Metadata
- Authors
- VanWagner, L. B., Wilcox, J. E., Colangelo, L. A., Lloyd‐Jones, D. M., Carr, J. J., Lima, J. A., Lewis, C. E., Rinella, M. E., & Shah, S. J.
- Venue
- Hepatology
- Published
- 2015-06-26
- Volume
- 62
- Issue
- 3
- Pages
- 773-783
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1995461319
- Cited by
- 305
- References
- 50
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.